ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation

Chia Jen Siao, Christina U. Lorentz, Pouneh Kermani, Tina Marinic, John Carter, Kelly McGrath, Victoria A. Padow, Willie Mark, Domenick J. Falcone, Cohen Gould Leona, Diana C. Parrish, Beth A. Habecker, Anders Nykjaer, Lora H. Ellenson, Lino Tessarollo, Barbara L. Hempstead

Research output: Contribution to journalArticle

39 Scopus citations

Abstract

Treatment of acute cardiac ischemia focuses on reestablishment of blood flow in coronary arteries. However, impaired microvascular perfusion damages peri-infarct tissue, despite arterial patency. Identification of cytokines that induce microvascular dysfunction would provide new targets to limit microvascular damage. Pro-nerve growth factor (NGF), the precursor of NGF, is a well characterized cytokine in the brain induced by injury. ProNGF activates p75 neurotrophin receptor (p75NTR) and sortilin receptors to mediate proapoptotic responses. We describe induction of proNGF by cardiomyocytes, and p75NTR in human arterioles after fatal myocardial infarction, but not with unrelated pathologies. After mouse cardiac ischemia-reperfusion (I-R) injury, rapid up-regulation of proNGF by cardiomyocytes and p75NTR by microvascular pericytes is observed. To identify proNGF actions, we generated a mouse expressing a mutant Ngf allele with impaired processing of proNGF to mature NGF. The proNGF-expressing mouse exhibits cardiac microvascular endothelial activation, a decrease in pericyte process length, and increased vascular permeability, leading to lethal cardiomyopathy in adulthood. Deletion of p75NTR in proNGF-expressing mice rescues the phenotype, confirming the importance of p75NTR-expressing pericytes in the development of microvascular injury. Furthermore, deficiency in p75NTR limits infarct size after I-R. These studies identify novel, nonneuronal actions for proNGF and suggest that proNGF represents a new target to limit microvascular dysfunction.

Original languageEnglish (US)
Pages (from-to)2291-2305
Number of pages15
JournalJournal of Experimental Medicine
Volume209
Issue number12
DOIs
StatePublished - Nov 2012

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation'. Together they form a unique fingerprint.

  • Cite this

    Siao, C. J., Lorentz, C. U., Kermani, P., Marinic, T., Carter, J., McGrath, K., Padow, V. A., Mark, W., Falcone, D. J., Leona, C. G., Parrish, D. C., Habecker, B. A., Nykjaer, A., Ellenson, L. H., Tessarollo, L., & Hempstead, B. L. (2012). ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation. Journal of Experimental Medicine, 209(12), 2291-2305. https://doi.org/10.1084/jem.20111749